Stockholders' Equity (Tables)

3 Months Ended

Nov. 30, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of Recognized Stock-based Compensation Expense

The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions):

	Three months ended
	November 30, 2022		November 30, 2021
Restricted stock units	$	38	$	32
Employee stock purchase plan	4		3
Total	$	42	$	35

Schedule of Share-based Compensation Information

The following represents the stock-based compensation information as of the period indicated (in millions):

	November 30, 2022
Unrecognized stock-based compensation expense—restricted stock units	$	79
Remaining weighted-average period for restricted stock units expense	1.5 years

Schedule of Common Stock Outstanding

The following represents the common stock outstanding for the periods indicated:

	Three months ended
	November 30, 2022	November 30, 2021
Common stock outstanding:
Beginning balances	135,493,980	144,496,077
Vesting of restricted stock	1,861,678	2,425,472
Purchases of treasury stock under employee stock plans	(523,407)	(690,555)
Treasury shares purchased(1)(2)	(2,600,951)	(2,064,985)
Ending balances	134,231,300	144,166,009

(1)In July 2021, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the Company’s common stock (the “2022 Share Repurchase Program”). As of November 30, 2022, 15.0 million shares had been repurchased for $898 million and $102 million remains available under the 2022 Share Repurchase Program.

(2)In September 2022, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the Company’s common stock (the “2023 Share Repurchase Program”). As of November 30, 2022, no shares had been repurchased under the 2023 Share Repurchase Program.